Ticker: RXRX | Published: 2026-09-18
AI drug narrative lifts RXRX
Fresh coverage spotlighting Recursion as a leading AI-driven drug discovery story is fueling a violent rally well ahead of the Nasdaq's own strong climb, with normal volume suggesting narrative-driven buying rather than a broad index move.
Sources: https://www.investing.com/news/stock-market-news/4907720, https://ca.investing.com/news/stock-market-news/4845